Tilak Mendis

1.3k total citations
15 papers, 414 citations indexed

About

Tilak Mendis is a scholar working on Neurology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Tilak Mendis has authored 15 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Psychiatry and Mental health and 2 papers in Molecular Biology. Recurrent topics in Tilak Mendis's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neurological disorders and treatments (4 papers) and Dementia and Cognitive Impairment Research (3 papers). Tilak Mendis is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Neurological disorders and treatments (4 papers) and Dementia and Cognitive Impairment Research (3 papers). Tilak Mendis collaborates with scholars based in Canada, United States and Belgium. Tilak Mendis's co-authors include Erich Mohr, Mark Stacy, Dee E. Silver, Philip Chaikin, James P. Sutton, N. M. Sussman, Akihisa Mori, Kathleen Hildebrand, Peter Paul De Deyn and Margaret Sampson and has published in prestigious journals such as Neurology, Movement Disorders and International Psychogeriatrics.

In The Last Decade

Tilak Mendis

14 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tilak Mendis Canada	11	247	98	90	84	66	15	414
Margherita Torti Italy	14	318 1.3×	91 0.9×	46 0.5×	16 0.2×	27 0.4×	21	474
Nicholas Mallard United Kingdom	9	108 0.4×	273 2.8×	32 0.4×	56 0.7×	18 0.3×	11	548
Gabriele Bellini Italy	12	307 1.2×	87 0.9×	70 0.8×	4 0.0×	57 0.9×	35	532
Maria Eliza Freitas Canada	11	169 0.7×	139 1.4×	37 0.4×	7 0.1×	18 0.3×	16	411
WilliamE. Bunney United States	8	89 0.4×	92 0.9×	141 1.6×	9 0.1×	30 0.5×	9	329
Govindan Gopinathan United States	11	274 1.1×	98 1.0×	43 0.5×	6 0.1×	24 0.4×	22	344
Randi Rubovits United States	7	203 0.8×	302 3.1×	200 2.2×	6 0.1×	37 0.6×	8	597
Antonio Vázquez Spain	12	284 1.1×	65 0.7×	57 0.6×	4 0.0×	18 0.3×	14	410
Victor Abler United States	14	252 1.0×	131 1.3×	158 1.8×	3 0.0×	51 0.8×	47	454
Christopher L. Chio United States	5	93 0.4×	247 2.5×	44 0.5×	8 0.1×	24 0.4×	8	427

Countries citing papers authored by Tilak Mendis

Since Specialization

Citations

This map shows the geographic impact of Tilak Mendis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilak Mendis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilak Mendis more than expected).

Fields of papers citing papers by Tilak Mendis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilak Mendis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilak Mendis. The network helps show where Tilak Mendis may publish in the future.

Co-authorship network of co-authors of Tilak Mendis

This figure shows the co-authorship network connecting the top 25 collaborators of Tilak Mendis. A scholar is included among the top collaborators of Tilak Mendis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilak Mendis. Tilak Mendis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Stacy, Mark, Dee E. Silver, Tilak Mendis, et al.. (2008). A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology. 70(23). 2233–2240. 142 indexed citations

Mohr, Erich, Tilak Mendis, Kathleen Hildebrand, & Peter Paul De Deyn. (2000). Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial. Movement Disorders. 15(6). 1230–1237. 67 indexed citations

Mendis, Tilak, Oksana Suchowersky, Anthony E. Lang, & Serge Gauthier. (1999). Management of Parkinson's disease a review of current and new therapies.. PubMed. 26(2). 89–103. 20 indexed citations

Knott, Verner, et al.. (1999). EEG and the Passive P300 in Dementia of the Alzheimer Type. Clinical Electroencephalography. 30(2). 64–72. 10 indexed citations

Mohr, Erich, N.P.V. Nair, Margaret Sampson, et al.. (1997). Treatment of Alzheimerʼs Disease with Sabeluzole. Clinical Neuropharmacology. 20(4). 338–345. 11 indexed citations

Mohr, Erich, Denise L. Walker, Margaret Sampson, Tilak Mendis, & Christopher Randolph. (1996). Utility of Clinical Trial Batteries in the Measurement of Alzheimer’s and Huntington’s Dementia. International Psychogeriatrics. 8(3). 397–411. 33 indexed citations

Mohr, Erich, et al.. (1996). A profile analysis of demented and nondemented Parkinson's disease patients.. PubMed. 69. 339–41. 17 indexed citations

Mendis, Tilak, Corlane Barclay, & Erich Mohr. (1996). Drug-Induced Psychosis in Parkinsonʼs Disease. CNS Drugs. 5(3). 166–174. 9 indexed citations

Mohr, Erich, Verner Knott, Margaret Sampson, et al.. (1995). Cognitive and Quantified Electroencephalographic Correlates of Cycloserine Treatment in Alzheimerʼs Disease. Clinical Neuropharmacology. 18(1). 28–38. 21 indexed citations

10.

Mohr, Erich, et al.. (1995). Late cognitive changes in Parkinson's disease with an emphasis on dementia.. PubMed. 65. 97–113. 30 indexed citations

11.

Mendis, Tilak, et al.. (1994). Symptomatic relief from treatment‐induced psychosis in Parkinson's disease: An open‐label pilot study with remoxipride. Movement Disorders. 9(2). 197–200. 11 indexed citations

12.

Mohr, Erich, et al.. (1994). Neurotransmitter replacement therapy in Alzheimer's disease.. PubMed. 19(1). 17–23. 12 indexed citations

13.

Mohr, Erich, et al.. (1992). SYMPTOMATIC RELIEF FROM TREATMENT INDUCED PSYCHOSIS IN PARKINSONʼS DESEASE: A PILOT STUDY WITH REMOXIPRIDE. Clinical Neuropharmacology. 15. 139B–139B. 1 indexed citations

14.

Mendis, Tilak, et al.. (1986). Bilateral Facial Paralysis Following Ethylene Glycol Ingestion. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 13(4). 340–341. 20 indexed citations

15.

Lal, Samarthji, et al.. (1979). Effect of Benztropine on Haloperidol-Induced Prolactin Secretion. Neuropsychobiology. 5(6). 327–331. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact